Thema
610
4
Recruitment Status: Not yet recruiting
4
Study Type: Interventional
4
Medical Condition: Enfermedad alérgica mediada por la inmunoglobulina E (IgE) en adultos y adolescentes que manifiestan rinitis/rinoconjuntivitis alérgica con o sin asma bronquial alérgica controlada (Iniciativa global para el asma [GINA]) desencadenada por alérgenos de ácaros del polvo no eliminables. MedDRA version: 12.0Level: LLTClassification code 10039085Term: Rhinitis allergic MedDRA version: 12.0Level: LLTClassification code 10001705Term: Allergic asthma
2
Medical Condition: PURETHAL is indicated for specific immunotherapy (desensitisation) of IgE-mediated, inhaled allergy with symptoms of allergic rhinitis, allergic conjunctivitis and allergic bronchial asthma with an allergic background. MedDRA version: 16.0Level: LLTClassification code 10001723Term: Allergic rhinitisSystem Organ Class: 100000004855;Therapeutic area: Diseases [C] - Ear, nose and throat diseases [C09]
2
Phase: Phase 3
2
Asthma
1
Der p 1
1
IgA deficiency
1
IgE sensitization
1
Medicine and Nursing
1
Mediterranean diet
1
NICE birth cohort
1
PUFAs
1
RSV
1
allergen
1
allergen molecules
1
allergic sensitization
1
allergy
1
anaphylaxis
1
arachidonic acid
1
asthma
1
atopic dermatitis
1
atopic eczema
1
atopy
1
bovine IgG
1
breastfeeding
1
breastmilk
1
childhood
1
children
1
cohort study
1
cord blood
1
cow’s milk allergy
1
cow’s milk allergy (CMA)
1
diagnosis
1
diet
1
early food introduction
1
early introduction
1
eczema
1
efficacy
1
epigenetics
1
fatty acids
1
foetal immune ontogeny
1
food allergy
1
functional gastrointestinal disorder
1
gene/environment interactions
1
house dust mite
1
hypoallergenic infant formula
1
immune complex
1
immune development
1
mehr ...